Women are twice as likely as men to be diagnosed with MS and 450,000 women in Europe are affected by the condition. CRA investigated the burden of MS on women patients and the implications on Europe’s economy and society. Our research found a significant impact for women in terms of their family life, career progression and labour market role, that is not recognised by current MS polices. Our analysis suggests a need for greater awareness initiatives to drive early diagnosis and multidisciplinary treatment approaches to facilitate timely access to care. Also, social and workplace support can increase participation in the labour force and social activities, supporting women, their families and the wider economy.
Part 2: Low-priced oncology disruptors: The cuckoo in the PD-1/PD-L1 nest or the runt of the clutch?
Healthcare coverage is heterogeneous across emerging markets, with public funding limited by budgetary constraints. This typically sees higher-priced drugs,...